Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for non-valvular atrial fibrillation - Graham, DJ; Reichman, ME; Wernecke, M (Circulation, 2014)
pii: CIRCULATIONAHA.114.012061.